Recently, the Beijing Municipal Bureau of Economy and Information Technology released the Notice on Issuing the List of the First Batch of Municipal-level Enterprise Technology Centers to be Established in Beijing in 2023. DHC was recognized as "Beijing Municipal-level Enterprise Technology Center". It reflects the Beijing municipal government's overall recognition of DHC's innovative and developmental achievements in innovation benefits, competitive advantages, technical level, research and development investment, intellectual property rights and other aspects.

Beijing Municipal Enterprise Technology Center is an authoritative recognition given by Beijing municipal government to enterprise technology centers with relatively strong technological innovation capability, significant innovation performance and important demonstration and guidance functions. It aims to implement the innovation-driven development strategy, boost the construction of Beijing International Science and Technology Innovation Center, implement the development plan of Beijing's high-tech industries in the "14^th Five-Year Plan" period, strengthen the dominant position of enterprises in technological innovation by cultivating and guiding the construction of enterprise technology centers, guide and support enterprises to enhance their technological innovation capabilities, and improve the market-oriented mechanism for technological innovation.

As a leading enterprise in medical big data and artificial intelligence in China, DHC has always adhered to independent technological innovation, adhering to the concept of "Extreme Technology, Infinite Health", and focusing on the development of innovative applications of big data and artificial intelligence technology in the medical field, to provide advanced products and excellent solutions for the whole ecology of health care, so as to create a beautiful and healthy future.

Since its establishment, DHC has always focused on the development of forward-looking technologies such as big data, artificial intelligence, cloud computing, machine learning, federal learning, and multimodal, and insisted on building a standard system of medical terms in accordance with international general standards, forming a closed loop of big data fusion-governance-analysis with multi-group learning and multi-modality. At present, more than 40 national scientific research projects and major national projects have been carried out in total. The data precipitation and technical experience cover specific diseases such as cancer, rare diseases, cardiovascular and cerebrovascular diseases, and kidney diseases. The Bank has participated in the construction of several national database platforms for specific diseases, and supported the development of multiple specific disease standard data sets. With the arrival of the big model era, DHC is relying on AI technology to drive industry innovation, realize AI strategic upgrade, build a leading domestic big model in the medical field, and comprehensively lead the multimodal big data medical AI industry.

Being recognized as "Beijing Enterprise Technology Center" this time is the full affirmation of Beijing Municipal Government on the comprehensive strength and competitive advantages of Shenzhou Medical in technology research and development, introduction and training of scientific and technological talents in recent years. In the future, DHC will continue to respond to the national call, adhere to independent technological innovation, actively play the leading role of enterprise technology center, continuously improve the enterprise innovation management system, better play to the advantages of the industry, and strive for greater breakthroughs in key technology control, talent accumulation, Industry-University-Research cooperation, and other aspects, to further promote the company to become an international leading medical big data and artificial intelligence enterprise.